Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies. (Q54258778)

http://europepmc.org/abstract/MED/29523582

26 May 2018

title

Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies. (English)

1 reference

http://europepmc.org/abstract/MED/29523582

26 May 2018

author

Stanislav O Fedechkin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523582%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Lawrence M Kauvar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523582%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Rebecca M DuBois

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523582%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Natasha L George

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523582%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Jacob T Wolff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523582%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

9 March 2018

1 reference

http://europepmc.org/abstract/MED/29523582

26 May 2018

published in

Science Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523582%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523582%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523582%20AND%20SRC:MED&resulttype=core&format=json

Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay

6 June 2020

cites work

1 reference

12 December 2020

Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus

1 reference

12 December 2020

Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells

1 reference

12 December 2020

Risk of primary infection and reinfection with respiratory syncytial virus

1 reference

12 December 2020

Solution structure of the immunodominant region of protein G of bovine respiratory syncytial virus

1 reference

12 December 2020

Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants

1 reference

12 December 2020

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

1 reference

12 December 2020

Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo

1 reference

12 December 2020

Structure-antigenicity relationship studies of the central conserved region of human respiratory syncytial virus protein G

1 reference

12 December 2020

Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P

1 reference

12 December 2020

Multiple heparin binding domains of respiratory syncytial virus G mediate binding to mammalian cells

1 reference

12 December 2020

Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells

1 reference

12 December 2020

Coot: model-building tools for molecular graphics

1 reference

12 December 2020

Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses

1 reference

12 December 2020

Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection

1 reference

12 December 2020

The burden of respiratory syncytial virus infection in young children

1 reference

12 December 2020

Phasercrystallographic software

1 reference

12 December 2020

Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice

1 reference

12 December 2020

Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients.

1 reference

12 December 2020

PHENIX: a comprehensive Python-based system for macromolecular structure solution

1 reference

12 December 2020

Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice.

1 reference

12 December 2020

iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM

1 reference

12 December 2020

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

12 December 2020

Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice

1 reference

12 December 2020

How good are my data and what is the resolution?

1 reference

12 December 2020

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

1 reference

12 December 2020

Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies

1 reference

12 December 2020

Community-acquired pneumonia requiring hospitalization among U.S. children

1 reference

12 December 2020

An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice

1 reference

12 December 2020

CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner

1 reference

12 December 2020

CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

1 reference

12 December 2020

Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures

1 reference

12 December 2020

Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins

1 reference

12 December 2020

Processing of X-ray diffraction data collected in oscillation mode

1 reference

12 December 2020

Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases

1 reference

12 December 2020

Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.

1 reference

12 December 2020

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective

1 reference

12 December 2020

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

1 reference

12 December 2020

Prefusion F, postfusion F, G antibodies and disease severity in infants and young children with acute respiratory syncytial virus infection

1 reference

12 December 2020

Respiratory Syncytial Virus (RSV): Targeting the G Protein Provides a New Approach for an Old Problem.

1 reference

12 December 2020

10.1126/SCIIMMUNOL.AAR3534

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523582%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29523582%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference